Preoperative use of anti-tumor necrosis factor therapy in Crohn's disease: promises and pitfalls
Recent advances in medical and surgical therapy were achieved during the last two decades in the management of Crohn's disease (CD). Anti-tumor necrosis factor (anti-TNF) agents are widely used worldwide. However, a significant proportion of patients still need surgical resections. The impact o...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Association for the Study of Intestinal Diseases
2017-04-01
|
Series: | Intestinal Research |
Subjects: | |
Online Access: | https://doi.org/10.5217/ir.2017.15.2.160 |